Cargando…

Telomere length and incident atrial fibrillation – data of the PREVEND cohort

BACKGROUND: The incidence of atrial fibrillation (AF) increases with age. Telomere length is considered a marker of biological ageing. We investigated the association between leukocyte telomere length and incident AF in the Dutch Prevention of Renal and Vascular End-stage Disease (PREVEND) study. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siland, Joylene E., Geelhoed, Bastiaan, van Gelder, Isabelle C., van der Harst, Pim, Rienstra, Michiel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291433/ https://www.ncbi.nlm.nih.gov/pubmed/28158257 http://dx.doi.org/10.1371/journal.pone.0171545

Ejemplares similares

Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations
por: Rienstra, Michiel, et al.
Publicado: (2016)

Lifestyle components: Self-reported physical activity, nutritional status, sleep quality and incident atrial fibrillation
por: Siland, Joylene E., et al.
Publicado: (2020)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Atrial fibrillation and left atrial size and function: a Mendelian randomization study
por: van de Vegte, Yordi J., et al.
Publicado: (2021)

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort
por: Van Deutekom, C, et al.
Publicado: (2023)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Atrial Fibrillation Genetics Update: Toward Clinical Implementation
por: Kalstø, Silje Madeleine, et al.
Publicado: (2019)

Incidence and outcome of atrial fibrillation: diversity throughout Europe
por: Rienstra, Michiel, et al.
Publicado: (2021)

Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women
por: Siland, J. E., et al.
Publicado: (2021)

Risk prediction of atrial fibrillation in the community combining biomarkers and genetics
por: Börschel, Christin S, et al.
Publicado: (2021)

Atrial fibrillation and heart failure temporality: does it matter?
por: Van Deutekom, Colinda, et al.
Publicado: (2022)

Update on management of atrial fibrillation in heart failure: a focus on ablation
por: Mulder, Bart A, et al.
Publicado: (2022)

Validating risk models versus age alone for atrial fibrillation in a young Dutch population cohort: should atrial fibrillation risk prediction be expanded to younger community members?
por: Himmelreich, Jelle C L, et al.
Publicado: (2022)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()
por: Marcos, Ernaldo G., et al.
Publicado: (2019)

Relation of overweight and symptomatic atrial fibrillation: A case report
por: de Maat, Gijs E., et al.
Publicado: (2015)

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
por: Brandes, Axel, et al.
Publicado: (2020)

Genetic risk and atrial fibrillation in patients with heart failure
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium
por: Siland, J. E., et al.
Publicado: (2022)

Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
por: Al-Jazairi, M. I. H., et al.
Publicado: (2019)

Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: Abbasi, Ali, et al.
Publicado: (2014)

Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study
por: Staerk, Laila, et al.
Publicado: (2017)

The Association between Intelligence and Telomere Length: A Longitudinal Population Based Study
por: Kingma, Eva M., et al.
Publicado: (2012)

Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study
por: Al-Jazairi, Meelad I H, et al.
Publicado: (2021)

Initial experience with pulsed field ablation for atrial fibrillation
por: Magni, Federico T., et al.
Publicado: (2022)

Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial
por: Nguyen, Bao Oanh, et al.
Publicado: (2021)

Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: (Additive) Value of Implantable Loop Recorders
por: Gorter, Thomas M., et al.
Publicado: (2023)

Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study
por: van de Lande, Martijn E, et al.
Publicado: (2023)

Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study
por: Sokooti, Sara, et al.
Publicado: (2021)

Urinary albumin excretion and cancer risk: the PREVEND cohort study
por: Luo, Li, et al.
Publicado: (2023)

Segment length in cine (SLICE) strain analysis: a practical approach to estimate potential benefit from cardiac resynchronization therapy
por: Zweerink, Alwin, et al.
Publicado: (2021)

Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study
por: Artola Arita, Vicente, et al.
Publicado: (2023)

Healthy aging and disease: role for telomere biology?
por: Zhu, Haidong, et al.
Publicado: (2011)

Telomere Length of Circulating Leukocyte Subpopulations and Buccal Cells in Patients with Ischemic Heart Failure and Their Offspring
por: Wong, Liza S. M., et al.
Publicado: (2011)

Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
por: Kloosterman, Mariëlle, et al.
Publicado: (2019)

Renal dysfunction is associated with shorter telomere length in heart failure
por: Wong, Liza S. M., et al.
Publicado: (2009)

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation
por: Korenstra, Jennie, et al.
Publicado: (2016)

HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study
por: Sokooti, Sara, et al.
Publicado: (2021)

Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study
por: Ekrami, Neda Khalilian, et al.
Publicado: (2022)

Identifying patients with atrial fibrillation recurrences after two pulmonary vein isolation procedures
por: Mulder, Bart A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_erd1egj2k7fl5t1t5j38js81pf